Muscle fatty acid (FA) metabolism is impaired in obesity and insulin resistance, reflected by reduced rates of FA oxidation and accumulation of lipids. It has been suggested that interventions that increase FA oxidation may enhance insulin action by reducing these lipid pools. Here, we examined the effect of endurance training on rates of mitochondrial FA oxidation, the activity of carnitine palmitoyltransferase-1 (CPT-1) and the lipid content in muscle of obese individuals and related these to measures of glucose tolerance.
The mechanisms linking obesity to the development of insulin resistance are not fully understood. However, it is becoming increasingly apparent that defects in skeletal muscle fatty acid (FA) metabolism are involved. In particular, a reduced capacity for FA oxidation (22,23) and accretion of lipids in skeletal muscle seems to play a crucial role in the etiology of insulin resistance (1, 20, 36) . Although the increase in muscle lipid content is manifested as an increase in triacylglycerol (TAG; 29), it is likely that elevated TAG stores may only be a marker of dysfunctional muscle FA metabolism, and that accumulations of more reactive lipids, such as diacylglycerol (DAG) or ceramides, are actually responsible for the insulin resistance. Indeed, there are now plausible mechanistic links between the development of insulin resistance and accumulation of DAG and ceramide in muscle (7) . Intramyocellular DAG levels are elevated in a number of models of insulin resistance (20,32), while ceramide content is increased in muscle from obese insulin resistant humans (1) . DAG can activate several isoforms of protein kinase C (PKC) which can impair insulin signal transduction to glucose transport via serine phosphorylation of insulin receptor substrate (IRS)-1 (39). In addition, ceramides can cause insulin resistance by preventing insulin-stimulated Akt serine phosphorylation and activation (33,37).
In addition to lipid accumulation, the obese/insulin resistant phenotype is characterized by an impaired capacity for FA oxidation which is associated with a reduction in the activity of muscle carnitine palmitoyltransferase-1 (CPT-1), the rate limiting step in the mitochondrial oxidation of FA's (23). Thus, it is likely that an impaired ability to FINAL ACCEPTED VERSION E-00587-2005. R1 4 transport and oxidize FA's in skeletal muscle mitochondria of these individuals exacerbates lipid accumulation.
Therefore, it has been proposed that interventions which increase FA oxidation may exert an insulin sensitizing effect on skeletal muscle, in part, by reducing the accumulation of cytosolic lipids (30). Endurance training, for example, enhances fat oxidation (16, 21, 31) and improves insulin sensitivity (8) . Thus, it is of interest to determine whether the improvement in muscle FA oxidation following endurance training in obese individuals is associated with a reduction in specific intramyocellular lipid pools that have a direct link with the development of insulin resistance, such as DAG and ceramide. However,
there is a paucity of data examining the effects of exercise training on skeletal muscle DAG and ceramide content. Recently, it was shown that training reduced skeletal muscle ceramide content in rats (10) while a cross-sectional study in humans was unable to demonstrate any differences in ceramide content in muscle from untrained and trained individuals (15) . We are unaware of any study that has examined the effect of exercise on muscle DAG content Therefore, in the present study we examined the effect of an endurance training program on rates of mitochondrial FA oxidation, as well as the activity of CPT-1 in skeletal muscle of obese individuals. Furthermore, we also determined the effect of training on skeletal muscle TAG, DAG and ceramide content. We hypothesized that the traininginduced increase in CPT-1 activity would enhance rates of mitochondrial FA oxidation FINAL ACCEPTED VERSION E-00587-2005. R1 5 leading to a reduction in muscle lipid content, and would be associated with an improvement in glucose tolerance.
Research design and methods

Subjects
Nine obese (BMI >30 kg/m 2 ) volunteers (4 male and 5 female) were studied. The physical characteristics of all participants are presented in Table 1 . For inclusion, volunteers were required to have maintained a stable weight (±2 kg) for at least 6 months prior to the study. None of the volunteers had type 2 diabetes, nor were they participating in any regular form of exercise before the study. The experimental protocol was approved by the University of Guelph ethics committee. The purpose, nature and potential risks of the study were explained to all subjects and informed written consent was obtained prior to participation.
Determination of peak oxygen uptake (VO 2 peak)
All subjects performed a progressive, incremental cycling test to volitional fatigue on an electronically-braked ergometer (Lode, Groningen, The Netherlands) for determination of VO 2 peak prior to, at the midpoint, and at the completion of the training program (described below).
Oral glucose tolerance test
One week before, and 36-48 h following completion of the training program, an oral glucose tolerance test (OGTT) was performed. Subjects reported to the laboratory 
Skeletal muscle biopsy
One week prior to training, and 36-48 h after completion of the training program, three biopsies of the v. lateralis muscle were obtained. Briefly, local anesthesia (1% lidocaine) was administered to the skin, subcutaneous tissue and fascia of the v. lateralis and an incision was made. Three separate sites on the same leg were prepared. Resting muscle biopsies were obtained using a Bergström needle. Muscle biopsy specimens (~200 mg) from the first two biopsies were cleaned of any visible non-muscle tissue and immediately placed in ice-cold medium I for isolation of mitochondria (described subsequently). Muscle obtained from the final biopsy (~100-150 mg) was immediately frozen and stored in liquid nitrogen until subsequent analysis.
Exercise training program
The exercise-training program consisted of 8 wk of ergometer cycling undertaken 5 d/wk under supervision in the laboratory. Subjects cycled for 60 min at 65-70% of pre-training VO 2 peak. The training intensity was verified by measuring VO 2 during the training session in the first week. After 4 wk of exercise training, VO 2 peak was reassessed and the training program adjusted, so that for the remaining 4 wk subjects cycled for 60 min at Whole body rates of substrate metabolism were determined from indirect calorimetry during a 20 min ride at 65% of pre-training VO 2peak during the first and last week of the program.
Diets
Subjects were required to complete a detailed 3-day food record prior to the pre-training OGTT and muscle biopsy procedures. For the post-training testing, subjects were instructed to replicate these diets. The macronutrient composition of the diets was 45%
carbohydrate, 38% fat and 17% protein. Subjects were instructed not to make any dietary changes during the study which was confirmed by analysis of food records obtained after 4 and 8 weeks of training. Body weight was stable during the study; thus the effects of training independent of weight loss were studied.
Blood biochemistry
Each blood sample was collected in a sodium-heparinized tube and immediately processed; 200 µL of blood was transferred into 1 mL of 0.6 N perchloric acid (PCA) and centrifuged for 2 min. The supernatant was then removed and stored at -80°C until the subsequent analyses of whole blood glucose which was determined in duplicate fluorometrically. The remaining blood was centrifuged for plasma collection and stored at -80°C for subsequent analysis. Plasma insulin and adiponectin concentrations were 
Isolation of mitochondria from skeletal muscle
To obtain a pure and intact mitochondrial fraction, differential centrifugation was used (6).
All procedures were performed at 0-4ºC. Media used were as follows: Teflon pestle (10 up and down strokes, 30% of maximal speed). The homogenate was spun at 800 g for 10 min at 4ºC. Subsarcolemmal (SS) mitochondria remained in the supernatant, which was removed and kept on ice. The intermyofibrillar (IMF) mitochondria were pulled down in the pellet which was resuspended in 5 volumes of medium II and treated with a protease (Sigma P5380, 0.025 mL/g) for 5 min to digest the myofibrils. Addition of 15 mL of ice-cold medium II was used to diminish the action of the protease. Samples were spun at 5,000 g for 5 min and the supernatant was removed. The pellet was resuspended in 10 volumes of medium II and spun at 800 g for 10 min. The IMF mitochondria found in the supernatant were combined with the SS supernatant from the first 800 g spin to increase the mitochondrial yield, and was spun at 10,000 g for 10 min. The pellet was washed twice in The forward radioisotope assay for the determination of CPT-1 activity was used as CPT-1 activity was expressed in terms of the whole muscle (nmol·min -1 ·kg wet muscle -1 ), and was normalized to the ratio of citrate synthase activity in intact mitochondrial suspensions to total muscle citrate synthase activity to account for the quality of the mitochondrial preparation (see below).
Skeletal muscle mitochondrial fatty acid oxidation
Muscle FA oxidation rate was determined in intact isolated mitochondria from the sum of temperatures were set at 250°C each. The oven temperature was increased linearly from 160 to 230°C at a rate of 5°C/min. Individual FA methyl esters were quantified using the area corresponding to the internal standards (Sigma). Total TAG, DAG and ceramide content was estimated as the sum of the particular FA content of the assessed fraction and was expressed in nanomoles per gram of tissue. 
Western blot anaylsis
Statistics and calculations
The insulin sensitivity index was calculated from the following formula (10,000/square root of [fasting glucose X fasting insulin] X [mean glucose X mean insulin during OGTT]) from Matusda and Defronzo (26). All data are reported as mean ± SEM.
sensitivity of CPT-1 to M-CoA was examined using a two-way ANOVA. Associations between variables were investigated using Pearson correlation analysis. Statistical significance was accepted at P<0.05.
Results
Subject characteristics
Subject characteristics are presented in Table 1 . Body mass and BMI did not change following training. VO 2 peak increased by 26% (P<0.001). No change was observed in fasting FA levels. Circulating adiponectin levels were significantly decreased with training (P<0.01).
Glucose tolerance
Exercise training had no effect on fasting blood glucose concentration, but reduced fasting plasma insulin (P<0.005; Table 1 ). Blood glucose and plasma insulin concentrations during the OGTT are shown in Figure 1A & B. The area under the curve for both glucose (P<0.05, Figure 1C ) and insulin (P=0.01, Figure 1D ) during the OGTT was reduced with training. The insulin sensitivity index improved by 34% with training (P=0.001, Figure 1E )
CPT-1 activity and oxidative enzymes
Maximal CPT-1 activity increased by ~250% with training (P=0.001; Figure 2A ).
Following training, CPT-1 was less sensitive to inhibition by M-CoA (main effect
P<0.05; Figure 2B ). The mitochondrial yield was 29±3%, while the quality was 89±1%
and was not different pre-vs. post-training. There was an increase in the activity of citrate synthase (68%, P<0.001; Table 2 ) and -HAD (36%, P<0.001; Table 2 ) with training.
Mitochondrial FA oxidation
The rate of mitochondrial FA oxidation increased by 120% following training (P<0.001; 
Skeletal muscle lipids
Training did not alter the FA composition or the content of skeletal muscle TAG (Table   3 ). Training resulted in a ~15% reduction in total DAG content in muscle (P=0.06; Table   4 ). There was a significant decrease in the C16:0 DAG species following training (P<0.05; Table 4 ). There were also reductions in C18:0 (-44%; P=0.07), C18:1 (-14%; P=0.07), and the sum of the saturated DAG FA's with training (-27%, P=0.06). Training resulted in a 42% decrease in total ceramide content in muscle (P=0.01; 
Discussion
It has been proposed that interventions that lead to an increased capacity for skeletal muscle FA oxidation, such as endurance training, may improve insulin action through a reduction in intramyocellular lipids. However, very little is known regarding the effect of endurance training on skeletal muscle lipids, in particular DAG and ceramide content.
Therefore, in the present study we examined whether the anticipated improvement in the capacity for muscle to oxidize FA following training would be associated with a reduction in intramuscular DAG and ceramide content in obese individuals. Here we report that endurance training increases CPT-1 maximal activity and reduces its sensitivity to inhibition by M-CoA, leading to increased rates of mitochondrial FA oxidation. This was associated with a reduction in the total content of ceramide and altered composition of ceramide-FA's in muscle. Furthermore, there was a trend for a reduction in total DAG content in muscle, as well as certain saturated DAG-FA species.
Importantly, these changes in intramuscular lipids were correlated to the observed improvement in glucose tolerance.
Effect of training on CPT-1 activity and mitochondrial FA oxidation
Carnitine palmitoyltransferase-1 is considered the rate limiting step in the oxidation of FA's. Carnitine palmitoyltransferase-1 activity is reduced in skeletal muscle from obese individuals and is likely to contribute to the suppressed rates of FA oxidation in obesity (23). Thus, obese muscle appears to be prone to partitioning FA's toward storage.
Although studies have shown that CPT-1 activity is increased in muscle of trained individuals (21,35), no studies have examined the effect of endurance training on CPT-1 activity in muscle of obese individuals. Furthermore, few studies have directly linked changes in CPT-1 activity with an alteration in mitochondrial FA oxidation. In the present study, CPT-1 activity was increased with training and this was associated with enhanced rates of mitochondrial FA oxidation. It is possible that the increase in both CPT-1 activity and mitochondrial FA oxidation could be solely due to an increase in mitochondrial density which occurs with training. To account for this possibility, we measured citrate synthase activity which is in direct proportion to muscle mitochondrial content (12) . Training resulted in a 68% increase in citrate synthase activity whereas CPT-1 activity increased by ~250% and mitochondrial FA oxidation increased 120% with training. Thus, an increase in mitochondrial density cannot entirely account for the improved fat oxidation. It is difficult to reconcile the mismatch in the relative increase in CPT-1 activity and mitochondrial FA oxidation, as it would be expected that changes in CPT-1 activity would be closely mirrored by changes in mitochondrial FA oxidation. It should be noted that the post-training CPT-1 activities reported here are similar to those reported in young healthy untrained individuals (35), and that the large increase in CPT-1 with training could be a function of the very low pre-training levels in our subjects.
Nevertheless, these adaptations to training appear to reflect both an increase in mitochondrial density and a change in mitochondrial function.
We also measured the effect of training on several regulators of skeletal muscle FA Due to limited sample size we were unable to determine M-CoA concentration. However,
we were able to demonstrate that with training CPT-1 became less sensitive to inhibition by M-CoA. This may be a potential mechanism to explain the increase in CPT-1 activity and subsequent enhancement of mitochondrial FA oxidation with training. However, this finding differs from a previous report that found an increased sensitivity of CPT-1 to MCoA in trained individuals (35). This seems paradoxical considering that endurance trained individuals have a greater capacity to oxidize FA (21). These differences between studies could be related to differences in the subject populations. The subjects in the current study were vastly different from Starritt et al (35) in that they were obese, less fit and had lower levels of CPT-1 activity pre-training. Nonetheless, the results of the present study offer new insight into the regulation of CPT-1 activity by M-CoA and subsequent mitochondrial FA oxidation in skeletal muscle following training.
Effect of training on skeletal muscle lipids
The major finding of the present study was that total ceramide content of skeletal muscle The accumulation of DAG in skeletal muscle has also been shown to be associated with the development of insulin resistance in rodents (39) and humans (1). DAG is a potent activator of a number of protein kinase C isoforms which can impair insulin-stimulated glucose uptake through inhibition of insulin receptor signaling at the level of IRS-1 (39).
To our knowledge, this is the first study to investigate the effect of endurance training on muscle DAG content in humans. Thus, we hypothesized that the increased capacity for FA oxidation following training would be associated with a reduction in skeletal muscle DAG content. Despite being unable to detect any significant change in the total DAG content with training, there was a strong trend for training to reduce DAG levels.
Apart from the content of lipid in the muscle, the composition of the lipids may also affect insulin action (14) . Indeed, in addition to the reduction in total ceramide content we also found that training altered the composition of individual ceramide-FA species in skeletal muscle. Following training there was reduction in the C16:0, C16:1, C18:1, C18:2, C20:0, while there was a trend for the C18:0 species to also decrease with training. This is consistent with the findings of Dobrzy (10) shown that well-trained individuals have increased muscle TAG content despite being insulin sensitive (13) . Thus, it has been hypothesized that intramyocellular TAG per se does not directly influence insulin action in skeletal muscle (13) . However, recent studies have demonstrated that in contrast to Goodpaster et al (13) , muscle TAG concentrations are not elevated in endurance trained individuals (3) and that training does not alter muscle TAG levels in healthy individuals (4) . Therefore, the effect of exercise training on muscle TAG content is equivocal. Nonetheless, taken together, the results from this study suggest that muscle DAG and ceramide play a more important role in the regulating insulin sensitivity than muscle TAG.
In conclusion, we show that endurance training increases maximal CPT-1 activity leading to enhanced rates of mitochondrial FA oxidation in vitro. This was associated with a reduction in the total content of ceramide and changes in the composition of ceramide-FA's in skeletal muscle of obese individuals. There was also a tendency for a reduction in total DAG content and the saturated DAG-FA species with training. These findings suggest that the improved capacity for mitochondrial FA uptake and oxidation not only leads to a reduction in muscle lipid content but also a change in the saturation status of lipids which may, at least in part, provide a mechanism for the enhanced insulin action observed with endurance training in obese individuals. Data are means ± SEM. Data is expressed as µmol/g dry wt. 
